(Q34911442)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19111629%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19111629%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19111629%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

K A Wesnes

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19111629%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A D P Dean

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19111629%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

S J Wroe

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19111629%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

25 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19111629%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19111629%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19111629%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19111629%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

522-528

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19111629%20AND%20SRC:MED&resulttype=core&format=json

Cognitive side effects of anti-epileptic drugs. The relevance in childhood epilepsy

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Cognitive and memory effects of the new antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Active control trials: endpoints beyond conventional efficacy and tolerability measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Cognition assessment in paediatric clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

The dos and don'ts of neuropsychological assessment in epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Factors Associated with Academic Achievement in Children with Controlled Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Efficacy and Safety of Remacemide versus Carbamazepine in Newly Diagnosed Epilepsy: Comparison by Sequential Analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Studies of interference in serial verbal reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Practice effects on cognitive tasks: a major problem?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Anticonvulsant drugs, cognitive function, and behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Phenytoin and carbamazepine: differential effects on cognitive function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Cognitive performances in newly referred patients with temporal lobe epilepsy: comparison with normal subjects in basal condition and after treatment with controlled-release carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Cognition and health-related quality of life in chronic well-controlled patients with partial epilepsy on carbamazepine monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Remacemide for drug-resistant localization related epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

A placebo-controlled, double-blind cross-over trial of adjunctive one month remacemide hydrochloride treatment in patients with refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Chronic exposure to NMDA receptor and sodium channel blockers during development in monkeys and rats: long-term effects on cognitive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Assessing the potential toxicity of MK-801 and remacemide: chronic exposure in juvenile rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Differential effects of two NMDA receptor antagonists on cognitive-behavioral development in nonhuman primates I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

Differential effects of two NMDA receptor antagonists on cognitive--behavioral performance in young nonhuman primates II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.11.012

10.1016/J.YEBEH.2008.11.012

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19111629%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference